Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avicanna Inc (AVCNF)

Avicanna Inc (AVCNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1400 +19.93%
on 12/11/25
0.1894 -11.35%
on 11/20/25
-0.0194 (-10.36%)
since 11/19/25
3-Month
0.1400 +19.93%
on 12/11/25
0.2228 -24.64%
on 10/13/25
-0.0183 (-9.83%)
since 09/18/25
52-Week
0.1150 +46.00%
on 04/07/25
0.2650 -36.64%
on 03/11/25
-0.0573 (-25.44%)
since 12/18/24

Most Recent Stories

More News
Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update

Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical affairs. TORONTO, Dec....

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform

PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Reports Q3 2025

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Announces Change in CFO

TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland

This marks the first export of organic certified flower for SMGH, 20 th international market for Aureus branded products and 23 rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States

re+PLAY is a CBD wellness brand founded by NBA veteran Al Harrington  with products utilizing Avicanna’s patented and proprietary CBD formulations. The initial launch of re+PLAY in the United...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Reports Q2 2025

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing,...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Announces US Patent and Trademark Office Issuance of New Patent

USPTO Issues Patent No. US 12,343,315 B2 covering topical cannabinoid compositions for clear skin TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ) (TSX:...

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Announces Results of Annual General Meeting

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)
Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain

AVCN.TO : 0.2250 (-2.17%)
AVCNF : 0.1679 (-2.78%)

Key Turning Points

3rd Resistance Point 0.1819
2nd Resistance Point 0.1749
1st Resistance Point 0.1714
Last Price 0.1679
1st Support Level 0.1609
2nd Support Level 0.1539
3rd Support Level 0.1504

See More

52-Week High 0.2650
Fibonacci 61.8% 0.2077
Fibonacci 50% 0.1900
Fibonacci 38.2% 0.1723
Last Price 0.1679
52-Week Low 0.1150

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar